Medtronic Reports Strong Q1 Fiscal 2027 Earnings
Medtronic (MDT) reported strong financial results for the first quarter of fiscal year 2027. The company achieved revenue of $9.8 billion and adjusted earnings per share (EPS) of $1.45, both exceeding expectations. Organic revenue growth reached 13.7%, driven by robust market demand and solid execution across key business segments such as CRM, CST, and Surgical. Medtronic's leadership highlighted the performance of its Cardiac Ablation Solutions and progress in areas like Symplicity, Altaviva, and Robotics with Hugo. The company emphasized that recent acquisitions are contributing to growth and strengthening its long-term portfolio. Management expressed confidence in maintaining strong commercial performance and achieving fiscal 2027 targets due to healthy market conditions and multiple scalable growth platforms.
Tickers: $MDT
Topics: Earnings Investor Relations Transcripts